In conclusion, our findings show that the assessment of monocyte subsets with PD-L1 expression and analysis of CD62L expression on all monocytes may be critical for predicting the COVID-19 course and identifying patients with a possible predisposition for rapid recovery. Here, SELL is linked to COVID-19.